Abiopharma

🔍 PYOTT DAVID E I (Director)

Company: Tarsus Pharmaceuticals, Inc. (TARS)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 1,383 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,383.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: H | nature_of_ownership: By the David E.I. Pyott Trust | shares_owned_after: 7,991.00
• Sold 1,383 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-24 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
• F2: Each RSU represents a contingent right to receive one share of the Company's common stock.
• F3: The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service.